retatrutide and liver Since January 2026, there have been six cases of acute toxicity associated with unapproved peptide products labelled in Australia. These toxic effects may be linked to a contaminant in the Retatrutide: A Multi-Receptor Approach to

These benefits were consistent regardless of CPAP use, supporting GLP-1 RAs as a promising adjunct in the management of OSA

Its been a weird shift from always looking for low-calorie options, but I pack those lower-appetite days with higher-calorie, nutritious foods

A nationwide cohort study of inflammatory bowel disease, histological activity and fracture risk

From a longevity medicine perspective, the combination of meaningful weight reduction, improved glycemic control, reduced hepatic fat, and potential cardiovascular benefit represents a multi-pathway intervention on metabolic aging

Their salutary and what appears to be marked impact beyond losing weight is getting validated in ways not fully anticipated, affecting cardiovascular outcomes, non-alcoholic fatty liver disease, and perhaps substance and behavioral addiction

GLP-1 medications have been shown to have anti-inflammatory effects, potentially easing these symptoms